BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31114343)

  • 1. Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification.
    Jiang T; Li M; Lin M; Zhao M; Zhan C; Feng M
    Cancer Manag Res; 2019; 11():2951-2961. PubMed ID: 31114343
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing Part-Solid and Pure-Solid Tumors in the TNM Classification of Lung Cancer (Eighth Edition).
    Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T
    Thorac Cardiovasc Surg; 2019 Jun; 67(4):306-314. PubMed ID: 29843187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
    Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.
    Wang C; Wu Y; Li J; Ren P; Gou Y; Shao J; Zhou Y; Xiao X; Tuersun P; Liu D; Zhang L; Li W
    Ann Transl Med; 2020 Sep; 8(18):1133. PubMed ID: 33240982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
    Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
    J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
    Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
    Sun K; You A; Wang B; Song N; Wan Z; Wu F; Zhao W; Zhou F; Li W
    Eur Radiol; 2021 Oct; 31(10):7353-7362. PubMed ID: 33860370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes of lobectomy
    Zheng YZ; Zhai WY; Zhao J; Luo RX; Gu WJ; Fu SS; Wu D; Yuan LX; Jiang W; Tsutani Y; Liao HY; Li XQ
    J Thorac Dis; 2020 Jun; 12(6):3178-3187. PubMed ID: 32642239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of segmentectomy
    Dai Z; Hu J; Shen C; Mi X; Pu Q
    J Thorac Dis; 2023 Aug; 15(8):4292-4305. PubMed ID: 37691674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Stratification According to Size and Dominance of Radiologic Solid Component in Clinical Stage IA Lung Adenocarcinoma.
    Nakao M; Oikado K; Sato Y; Hashimoto K; Ichinose J; Matsuura Y; Okumura S; Ninomiya H; Mun M
    JTO Clin Res Rep; 2022 Feb; 3(2):100279. PubMed ID: 35199054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
    Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
    Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
    Shigefuku S; Ito H; Miura J; Kikuchi A; Isaka T; Adachi H; Nakayama H; Ikeda N
    Ann Surg Oncol; 2023 Feb; 30(2):830-838. PubMed ID: 36282457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer.
    Sui X; Jiang W; Chen H; Yang F; Wang J; Wang Q
    J Thorac Oncol; 2017 Nov; 12(11):1679-1686. PubMed ID: 28782726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.
    Liu S; Chen S; Ma K; Shao Z
    Cancer Cell Int; 2018; 18():166. PubMed ID: 30386175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CXCR7 as a Common Predictor for Prognosis in Solid Tumors: a Meta-Analysis.
    Zhao Q; Zhang P; Qin G; Ren F; Zheng Y; Qiao Y; Sun T; Zhang Y
    J Cancer; 2018; 9(17):3138-3148. PubMed ID: 30210637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.